B. Huang, et al.
B
B
A-GeneralSubjects1864(2020)129698
competitively inhibit YwlE [8]. Nevertheless, in addition to oxidative
stress, it remains unknown whether other factors, such as metal cations
and oxyanions, regulate YwlE activity. Although YwlE is not considered
a metalloenzyme, metal cations play critical roles in its phosphatase
activity [10]. There are known and putative metal homeostasis systems
for Ca2+, Mg2+, Co2+, Ni2+, Zn2+, Cd2+ and Mn2+ in Bacillus subtilis
[11]. Therefore, it is important to understand how the metal ions affect
YwlE activity. Additionally, inorganic phosphate, a competitive in-
hibitor of phosphatase, is the hydrolytic product of the phosphatase
reaction. Oxyanions that are structurally analogous to phosphate con-
sequently inhibit phosphatase activity. Moreover, the stress tolerance
and virulence of the human pathogen Staphylococcus aureus is closely
related to protein arginine phosphorylation regulation mediated by
YwlE [3]. This finding taken together with our discovery of hundreds of
pArg proteins in human cancer cells suggests that understanding how
oxyanions regulate YwlE activity may facilitate the development of
anti-bacterial or anticancer drugs.
Here, we investigate the effect of metal ions, oxyanions, phospha-
tase inhibitors, reducing reagents, and non-hydrolysable analogs of
pArg on the phosphatase activity of YwlE from Bacillus subtilis using the
chromogenic substrate p-nitrophenyl phosphate (pNPP), which is a
nonspecific phosphatase substrate favoring continuous assays of phos-
phatases at alkaline pH values. We also discuss the general problems
encountered with the inhibition and activation effects in the literature.
37 °C overnight and then diluted with 500 mL fresh Luria-Bertani media
with the same antibiotics. Cells were allowed to grow at 37 °C under
220 rpm orbital shaking until an OD600 nm of 0.7 was reached. Protein
expression was induced with the addition of IPTG (isopropyl β-D-
thiogalactoside) to a final concentration of 0.5 mM for 3 h at 37 °C
under 200 rpm orbital shaking. Cells were harvested by centrifugation
and lysed in lysis buffer [pH 8.0, 20 mM Tris-HCl, 300 mM NaCl, 1 mM
PMSF (phenylmethanesulfonyl fluoride)] with cell disruptor. After
centrifugation at 11,000 rpm for 30 min to remove cell debris, the su-
pernatant was loaded on Ni2+-NTA column (BBI Life Sciences) for af-
finity capture of the His-tag target protein. The column was then wa-
shed with 5 mM imidazole and eluted with 50 mM imidazole. The
eluted protein was further purified using size-exclusion chromato-
graphy with a Superdex G75 column. The purified YwlE protein was
dialyzed into storage buffer [pH 7.6, 20 mM Tris/HCl, 100 mM NaCl],
and the concentration was determined using the Bradford assay.
The gene encoding YwlE was derived from Bacillus subtilis. The
mutant construct YwlE (C7S) was generated with a site-directed mu-
tagenesis kit (TAKARA) using the primers 5′-GGATATTATTTTTGTCA
GCACTGGAAATAC-3′ and 5′-GCGGCACGTATTTCCAGTGCTGACAAAA
ATAT-3′. The mutant construct YwlE (C7A) was generated similarly
using primers 5′-GGATATTATTTTTGTCGCTACTGGAAATAC-3′ and
5′-CACGTATTTCCAGTAGCGACAAAAATAATAT-3′. All constructs were
verified by DNA sequencing. The mutant plasmids were transformed
into E. coli BL21 (DE3) cells (Novagen) for mutant protein expression.
The expression and purification of the mutant protein were carried out
using the same protocols used for the wild-type YwlE.
2. Materials and methods
2.1. Reagents and materials
Briefly, p-nitrophenyl phosphate (pNPP) was purchased from J&K
Scientific (Shanghai, China). Tris, HEPES, PIPES (piperazine-1,4-bi-
sethanesulfonic acid), DTT (dithiothreitol), β-me (β-mercaptoethanol)
and TCEP·HCl (tris(2-carboxyethyl)phosphine hydrochloride) were
purchased from Sangong Biotech. NaCl (sodium chloride), CaCl2 (cal-
cium chloride), ZnCl2 (zinc chloride), CuCl2 (cupric chloride), MgCl2
(magnesium chloride), MnCl2 (manganese chloride), NiCl2 (nickel
chloride), LiCl (lithium chloride), NaNO3 (sodium nitrate), Na2CO3
(sodium carbonate), Na2SO4 (sodium sulfate), Na2B4O7 (sodium bo-
rate), Cd(NO3)2 (cadmium nitrate), K2C2O4 (potassium oxalate mono-
2.3. McsB phosphorylated Arg-peptide
The synthetic Arg-peptide (40 μM) (S1·F) was enzymatically phos-
phorylated using protein arginine kinase McsB (15 μM) in reaction
buffer-A [pH 8.0, 20 mM Tris-HCl] supplemented with 1 mM adenosine
triphosphate (ATP) and 5 mM MgCl2 at 30 °C for 1 h. Phosphorylated
Arg-peptide (pArg-peptide, molecular weight: 1509.8 Da) was analyzed
by RP-HPLC and mass spectrometry. RP-HPLC was performed on an
Agilent 1260 instrument equipped with an Agilent ZORBAX 300Extend-
C18 (3.5 μm, 2.1 × 100 mm) column at a flow rate of 0.8 mL/min. The
elution was performed employing gradients of solvent A (0.1% formic
acid in water) and solvent B (95% acetonitrile in water with 0.1%
formic acid). A Bruker micrOTOF-Q-II mass spectrometry was con-
nected using split flow for mass detection. The MS parameters were as
follows: nebulizer 8 bar, dry gas 4.5 L/min, temperature 200 °C, posi-
tive mode, target mass, and scan range m/z 110–2000. Data processing
and analysis were performed using Data Analysis 4.1 (Bruker).
hydrate),
Na2MoO4•2H2O
(sodium
molybdate
dihydrate),
Na2WO4•2H2O (sodium tungstate dihydrate), H3BO3 (boric acid),
AgNO3 (silver nitrate), CoCl2 (cobaltous chloride), H2O2 (hydrogen
peroxide), NaF (sodium fluoride), Na3VO4 (sodium vanadate), and
Na4P2O7 (sodium pyrophosphate) were obtained from Sinopharm
Chemical Reagent, and β-glycerophosphate was obtained from Tokyo
Chemical Industry. IAM (iodoacetamide), pTyr (phosphotyrosine), pSer
(phosphoserine) and phosphocreatine were obtained from Sigma-
Aldrich. The protease/phosphatase inhibitor cocktail was obtained
from Thermo Fisher (No. 88668). The synthesis of pAIE (2-((2-ammo-
nioethyl)amino)-2-iminoethyl phosphonic acid) was performed ac-
cording to our previous work [12].
2.4. YwlE hydrolyzed pArg-peptide, pNPP, phosphocreatine and pArg in
vitro
N-terminally acetylated Arg-peptide derived from CtsR
(MW = 1429.8 Da, sequence see Fig. S1·F) was synthesized and HPLC
purified to 95% purity. The peptide was then lyophilized and dissolved
in distilled water as stock solution (5 mg/mL) for further assays.
Dephosphorylation of pArg-peptide was performed with YwlE
(1 μM) in buffer-A [pH 8.0, 20 mM Tris-HCl] at 30 °C for 1 h. Analysis of
dephosphorylation of pArg-peptide was performed using the same
process mentioned above via RP-HPLC and Bruker micrOTOF-Q-II.
Dephosphorylation of pNPP, phosphocreatine and pArg by YwlE
were performed at 30 °C for 1 h. For control assays, pNPP, phospho-
creatine and pArg were dissolved in buffer-A, separately. D2O was
added to a final concentration of 10% (v/v) to prepare NMR samples.
The reactions were characterized by 31P spectra acquired at 298 K using
a Bruker Avance III 600 MHz spectrometer equipped with triple re-
sonance cryogenic probes. Spectral width of 31P spectra were set to
400.0 ppm with a transmitter frequency offset of −50.0 ppm. All the
spectra with the same parameters were processed and analyzed using
Topspin 3.2 (Bruker).
2.2. Expression and purification of McsB, YwlE, YwlE (C7A) and YwlE
(C7S)
Expression and purification of McsB (Geobacillus stearothermophilus)
were performed according to our previous work [12]. The plasmid
encoding the Bacillus subtilis ywlE gene inserted into vector pET-21a(+)
containing a C-terminal 6 × His-tag was a generous gift from Prof.
Changwen Jin at Peking University. The plasmid was transformed into
E. coli BL21 (DE3) cells (Novagen). The cells were first cultured in 5 mL
fresh Luria-Bertani media supplemented with 50 μg/mL ampicillin at
2